If I Sell CBD Tinctures, How Do I Stay Under the 0.4 mg THC Cap?

Short answer: Build your compliance program around the finished tincture’s total THC per retail container, not just delta-9 THC or the amount in one serving. Use verified low-THC inputs, test representative finished batches with an independent laboratory, and hold products that do not meet your release limit. Also verify the effective date before changing labels or shipping plans: the widely discussed federal deadline may not be December 11.

This is a compliance planning guide, not legal advice. Federal and state requirements can change, and a product that meets one federal definition may still face state restrictions, FDA requirements, or carrier and retailer policies.

First, check the deadline instead of relying on a date circulating online

The federal hemp-law changes discussed in connection with a 0.4 mg total THC per container cap have been associated with an effective date one year after enactment. If the relevant law was enacted on November 12, 2025, that points to November 12, 2026—not December 11, 2026. Because deadlines can be affected by the exact statutory text, later amendments, agency guidance, and how a rule applies to a particular product, confirm the date against the enacted law and current agency materials before making business decisions.

If a supplier, consultant, or trade update tells you that December 11 is the deadline, ask for the specific legal citation and whether the date refers to enactment, effective date, a transition period, or a separate state or agency deadline. Do not treat a trade-calendar date as controlling without checking its source.

Legal language in one sentence: The effective date is when the new statutory standard is scheduled to apply; it is not automatically the date every business must stop selling every existing product, so verify any transition or sell-through provision in the law.

What the 0.4 mg tincture THC cap means in practice

A cap of 0.4 mg total THC per container is a limit on the contents of the retail package, not a per-serving allowance. A 30 mL bottle does not get a separate allowance for each dropperful. If the bottle contains 30 servings, the relevant question is still how much total THC is in the whole bottle under the applicable legal definition.

That distinction makes dose-based label language a poor substitute for product testing. “Less than 0.01 mg per serving” may sound low, but multiplying the measured or estimated amount by every serving in the bottle can put the package over the cap. And a “THC-free” claim is not a compliance strategy: make it only if the test method, reporting limit, and applicable rules support it.

What you check Why it matters Total THC in the whole retail container The proposed cap is expressed per container, not per serving. Delta-9 THC and THCA A delta-9-only result may miss THCA that counts toward total THC. Actual fill volume and package configuration A larger bottle or a changed serving count can change the total per container. Test method, units, and reporting limits Results must be interpretable against a very small milligram-per-package limit.

Plan for total THC, not delta-9 alone

The policy shift to watch is from focusing on delta-9 THC alone to a broader measure of total THC that includes THCA. THCA is the acidic precursor to delta-9 THC. It can convert to delta-9 THC when heated, so a product may show little delta-9 THC in a test while still containing THCA that counts under a total-THC calculation.

In many testing contexts, a commonly used calculation is:

Total THC = delta-9 THC + (0.877 × THCA)

The 0.877 factor accounts for the mass lost when THCA converts to delta-9 THC. Do not assume that this formula, a particular rounding convention, or a specific method is the controlling legal calculation for every product. Check the statute, applicable agency guidance, and laboratory method. Ask the lab to report the individual analytes and clearly state how any total is calculated.

For a tincture, test the finished formula rather than relying only on an ingredient certificate. Extraction, blending, carrier oils, and filling can create differences between the raw input result and the final product. If the formula uses multiple cannabinoid ingredients, the supplier’s label or certificate alone will not establish the total THC in the packaged bottle.

A practical batch-testing plan for tinctures

Batch testing tinctures is most useful when it is built into production controls—not treated as a document collected after the product is already for sale. Set a conservative internal release limit below the legal cap, leaving room for analytical uncertainty, production variation, and package-fill differences. A result that sits exactly at the cap is not a comfortable operating margin.

Qualify each supplier and input.
Request current certificates of analysis (COAs) for hemp extract, isolate, broad-spectrum ingredients, carrier oils where relevant, and any other cannabinoid-containing material. Confirm that the documents identify the supplier, material, lot or batch, test date, method, and results. Check that the COA covers both delta-9 THC and THCA when those analytes are relevant.
Specify THC limits in purchasing documents.
Put measurable specifications and rejection terms in supply agreements. “Hemp-derived” does not mean that an input has zero THC. Ask for lot-specific results and a clear process for notifying you about a change in source, extraction method, or formulation.
Use an independent laboratory.
Choose a qualified third-party lab that can quantify the relevant cannabinoids at concentrations low enough to assess your internal release target. Ask about its method, matrix validation for tinctures, measurement uncertainty, and reporting limit. If the lab’s reporting limit is too high to tell whether your bottle meets your target, the result does not resolve the compliance question.
Test the finished product by production batch.
Use a documented sampling plan that represents the actual bottled batch. Test the finished tincture in its marketed formulation, and retain the batch record, sample information, COA, and release decision. Re-test when a key input, formula, process, fill volume, or supplier changes.
Convert the result to milligrams per container.
Check the units carefully. A lab may report concentration as a percentage, milligrams per gram, or milligrams per milliliter. Convert the result using the actual product density or validated conversion and the actual fill quantity. Have a qualified person review the arithmetic before approving the batch.
Hold, investigate, and document out-of-spec results.
Do not average a failing result with a passing one to make the batch appear compliant. Quarantine affected inventory, investigate the input and manufacturing records, and consult your regulatory and legal advisers about retesting, remediation, relabeling, or disposition.

Keep the unit conversion simple—and checked

For a liquid reported in milligrams per milliliter, multiply the measured concentration by the actual fill volume to estimate milligrams per container. For example, if a lab reports 0.01 mg/mL and the bottle contains 30 mL, the estimated amount is 0.30 mg per bottle. That is below 0.4 mg on the arithmetic alone, but it may leave little margin once measurement uncertainty, fill variation, and the legally required calculation are considered. Confirm the lab’s units and the relevant method before using any conversion.

Choose THC-free inputs carefully

THC-free inputs can reduce risk, but the phrase needs evidence behind it. A supplier may use “THC-free” to describe a process or product category without guaranteeing that every lot is analytically zero. Ask what the term means in the supplier’s specification, what analytes were tested, how low the method can reliably measure, and whether the result is tied to the lot you are buying.

“Not detected” also does not necessarily mean absolute zero. It generally means the analyte was not detected above that method’s reporting or detection threshold. For a small package-level cap, a high reporting limit can conceal a meaningful amount when multiplied across the full bottle. Maintain the COA, verify the lot identity, and test the finished tincture even when an input is marketed as THC-free.

Publish batch lab results online—but publish them responsibly

Batch lab results posted online help customers, retailers, and compliance teams connect a product to its evidence. Make the COA easy to find from the product page or package QR code, and ensure the batch or lot number on the bottle matches the report. A general “see our lab results” link to an undated or unrelated document does not give a buyer meaningful batch transparency.

Show the product name, lot number, sample identity, lab, test date, and results.
Use a report that includes delta-9 THC and THCA where relevant, along with the method and units.
Do not present “not detected” as proof of absolute zero; provide the reporting limit when available.
Replace outdated reports when a new batch is released, and keep an internal archive of earlier versions.
Ensure marketing claims match the tested product and comply with labeling and advertising rules.

Some brands, including Joy Organics, have made public testing information part of their customer-facing quality approach. That can be a useful transparency model, but another company’s practices do not establish that your own product meets a legal limit. Your evidence must match your formula, batch, package, and claims.

Why flower shipments are at the highest risk

Flower shipments deserve particular attention. Raw flower can contain substantial THCA even when delta-9 THC is low, and a total-THC approach can therefore produce a very different compliance picture from a delta-9-only screen. Flower is also a less uniform material than a well-mixed tincture: cannabinoid levels may vary across buds, portions, and samples. A single test that is not representative of the shipment can miss that variability.

That does not mean tinctures are automatically safe. A tincture must still meet the applicable limit per container and satisfy the relevant testing and labeling requirements. But sellers should not assume that a flower COA showing low delta-9 THC is sufficient for interstate shipment, or that the same sampling approach works equally well for flower and a finished liquid product.

Track federal, state, and customer requirements separately

USDA (US Department of Agriculture) oversees parts of the federal hemp-production framework, while other federal agencies and states may regulate finished products, labeling, ingredients, claims, and sales. A federal hemp definition is not a blanket approval to sell a tincture everywhere. Check the rules in every state where you manufacture, warehouse, advertise, or ship, and confirm whether a retailer or marketplace imposes stricter specifications.

The US Hemp Roundtable and other trade organizations can be useful for tracking legislative developments and industry responses. Treat trade updates as a starting point: confirm consequential claims—especially deadlines, definitions, and transition rules—against the enacted law, official agency materials, or counsel.

Before you ship: a tincture compliance checklist

Confirm the current effective date and the legal definition that applies to your product.
Calculate total THC per complete retail container, not merely per serving.
Account for THCA as well as delta-9 THC where required.
Buy traceable inputs and verify lot-specific supplier COAs.
Set an internal release threshold below the legal maximum.
Use third-party lab testing with an appropriate method and low enough reporting limits.
Retest finished batches after meaningful supplier, formula, process, or package changes.
Post matching batch lab results online and retain complete records.
Review state rules, shipping restrictions, labels, and claims before distribution.

Bottom line: The most defensible way to stay under a tincture THC cap is to control THC at the en.mercopress.com input stage, measure total THC—including THCA when applicable—in the finished bottle, and maintain a documented margin below the limit. Verify the December 11 date rather than assuming it is the federal deadline, and do not release a batch based on a delta-9-only result or a supplier’s “THC-free” claim.